Polyembo secures funding led by a strategic investor to advance its innovative vascular embolic technology, the Scrunchy. The funding will support product development and regulatory clearances.

Oct 24, 2025•about 2 months ago

Longmontmedical devicesMedicalBiotechnologyHealth CareManufacturing

Investors

Strategic Investor

Description

Polyembo, a medical device company, announced the closure of a new funding round. The funding, led by a multinational strategic investor, will be utilized for advancing their vascular embolization technologies. The Scrunchy device addresses existing challenges with current products. This funding marks a significant step forward for Polyembo's product development and regulatory efforts.

Company Information

Company

Polyembo

Location

350 Terry St

Longmont, Colorado, United States

About

Polyembo is a privately held medical device company focused on developing novel vascular embolization technologies such as the Scrunchy, Sphere, and PuffyCoil. These innovative devices aim to enhance the precision and efficiency of embolic procedures, addressing key challenges faced in the market. The Scrunchy is designed to provide rapid occlusion with a simplified inventory requirement. Currently, these products are under development and do not have marketing clearance or approval.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns